Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis
Fungal keratitis (FK) is a refractory keratitis caused by excessive inflammation and fungal damage. Excessive inflammation can lead to tissue damage and corneal opacity, resulting in a poor prognosis for FK. Oxymatrine (OMT) is a natural alkaloid, which has rich pharmacological effects, such as anti...
Gespeichert in:
Veröffentlicht in: | Experimental eye research 2024-03, Vol.240, p.109830-109830, Article 109830 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 109830 |
---|---|
container_issue | |
container_start_page | 109830 |
container_title | Experimental eye research |
container_volume | 240 |
creator | Liu, Weichen Tian, Xue Gu, Lingwen Yu, Bing Wang, Ziyi Chi, Menghui Lin, Jing Wang, Qian Liu, Guibo Zhao, Guiqiu Cui Li |
description | Fungal keratitis (FK) is a refractory keratitis caused by excessive inflammation and fungal damage. Excessive inflammation can lead to tissue damage and corneal opacity, resulting in a poor prognosis for FK. Oxymatrine (OMT) is a natural alkaloid, which has rich pharmacological effects, such as antioxidant and anti-inflammation. However, its antifungal activity and the mechanism of action in FK have not been elucidated. This study confirmed that OMT suppressed Aspergillus fumigatus growth, biofilm formation, the integrity of fungal cell and conidial adherence. OMT not only effectively reduced corneal fungal load but also inflammation responses. OMT lessened the recruitment of neutrophils and macrophages in FK. In addition, OMT up-regulated the expression of Nrf2 and down-regulated the expression of IL-18, IL-1β, caspase-1, NLRP3 and GSDMD. Pre-treatment with Nrf2 inhibitor up-regulated the expression of IL-1β, IL-18, caspase-1, NLRP3 and GSDMD supressed by OMT. In conclusion, OMT has efficient anti-inflammatory and antifungal effects by suppressing fungal activity and restricting pyroptosis via Nrf2 pathway. OMT is considered as a potential option for the treatment of FK.
•Oxymatrine alleviated the severity of mouse fungal keratitis.•Oxymatrine exerted antifungal effects to suppress A. fumigatus growth.•Oxymatrine lessened infiltration of neutrophils and macrophages in mouse fungal keratitis.•Oxymatrine suppressed the excessive inflammatory response by inhibiting pyroptosis via Nrf2 pathway during fungal infections. |
doi_str_mv | 10.1016/j.exer.2024.109830 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2928246010</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014483524000514</els_id><sourcerecordid>2928246010</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-f7f4e44516fbb2006668b443c5cfd3773d720c08d494b6eeaafb0d7101773d9c3</originalsourceid><addsrcrecordid>eNp9kE9v1DAQxS1ERZfCF-CAcuSSZWJ7nUTiUlVtQarUC5wtx5msvOQfHqdqvn0n2sKRk0fvvXka_4T4VMC-gMJ8Pe3xGeNegtQs1JWCN2LHg8kBoHwrdgCFznWlDpfiPdGJVaVL_U5cqkoZXSu5E-Pj8zq4FMOI2RBSOLqElF3TjPEY-n6hrFuGTeXpN0aXOENZs2a0zHNEojAeOTIeXZ85n8JTSGvmxjZjj1tZYX9e4zSniQJ9EBed6wk_vr5X4tfd7c-b7_nD4_2Pm-uH3CsoU96VnUatD4XpmkYCGGOqRmvlD75rVVmqtpTgoWp1rRuD6FzXQFsylc2rvboSX869c5z-LHyKHQJ57Hs34rSQlbWspDZQAEflOerjRBSxs3MMg4urLcBunO3JbpztxtmeOfPS59f-pRmw_bfyFywHvp0DyL98CrxOPuDosQ0RfbLtFP7X_wKEapH4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2928246010</pqid></control><display><type>article</type><title>Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Liu, Weichen ; Tian, Xue ; Gu, Lingwen ; Yu, Bing ; Wang, Ziyi ; Chi, Menghui ; Lin, Jing ; Wang, Qian ; Liu, Guibo ; Zhao, Guiqiu ; Cui Li</creator><creatorcontrib>Liu, Weichen ; Tian, Xue ; Gu, Lingwen ; Yu, Bing ; Wang, Ziyi ; Chi, Menghui ; Lin, Jing ; Wang, Qian ; Liu, Guibo ; Zhao, Guiqiu ; Cui Li</creatorcontrib><description>Fungal keratitis (FK) is a refractory keratitis caused by excessive inflammation and fungal damage. Excessive inflammation can lead to tissue damage and corneal opacity, resulting in a poor prognosis for FK. Oxymatrine (OMT) is a natural alkaloid, which has rich pharmacological effects, such as antioxidant and anti-inflammation. However, its antifungal activity and the mechanism of action in FK have not been elucidated. This study confirmed that OMT suppressed Aspergillus fumigatus growth, biofilm formation, the integrity of fungal cell and conidial adherence. OMT not only effectively reduced corneal fungal load but also inflammation responses. OMT lessened the recruitment of neutrophils and macrophages in FK. In addition, OMT up-regulated the expression of Nrf2 and down-regulated the expression of IL-18, IL-1β, caspase-1, NLRP3 and GSDMD. Pre-treatment with Nrf2 inhibitor up-regulated the expression of IL-1β, IL-18, caspase-1, NLRP3 and GSDMD supressed by OMT. In conclusion, OMT has efficient anti-inflammatory and antifungal effects by suppressing fungal activity and restricting pyroptosis via Nrf2 pathway. OMT is considered as a potential option for the treatment of FK.
•Oxymatrine alleviated the severity of mouse fungal keratitis.•Oxymatrine exerted antifungal effects to suppress A. fumigatus growth.•Oxymatrine lessened infiltration of neutrophils and macrophages in mouse fungal keratitis.•Oxymatrine suppressed the excessive inflammatory response by inhibiting pyroptosis via Nrf2 pathway during fungal infections.</description><identifier>ISSN: 0014-4835</identifier><identifier>EISSN: 1096-0007</identifier><identifier>DOI: 10.1016/j.exer.2024.109830</identifier><identifier>PMID: 38364932</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Antifungal Agents - pharmacology ; Antifungal Agents - therapeutic use ; Aspergillosis - drug therapy ; Aspergillosis - metabolism ; Aspergillus fumigatus - physiology ; Aspergillus fumigatus keratitis ; Caspase 1 - metabolism ; Corneal Ulcer ; Eye Infections, Fungal - drug therapy ; Eye Infections, Fungal - metabolism ; Inflammation ; Interleukin-18 ; Keratitis - microbiology ; Matrines ; Mice ; Mice, Inbred C57BL ; NF-E2-Related Factor 2 ; NLR Family, Pyrin Domain-Containing 3 Protein ; NLRP3 ; Oxymatrine ; Pyroptosis</subject><ispartof>Experimental eye research, 2024-03, Vol.240, p.109830-109830, Article 109830</ispartof><rights>2024 Elsevier Ltd</rights><rights>Copyright © 2024 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c307t-f7f4e44516fbb2006668b443c5cfd3773d720c08d494b6eeaafb0d7101773d9c3</cites><orcidid>0000-0003-4643-072X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014483524000514$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38364932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Weichen</creatorcontrib><creatorcontrib>Tian, Xue</creatorcontrib><creatorcontrib>Gu, Lingwen</creatorcontrib><creatorcontrib>Yu, Bing</creatorcontrib><creatorcontrib>Wang, Ziyi</creatorcontrib><creatorcontrib>Chi, Menghui</creatorcontrib><creatorcontrib>Lin, Jing</creatorcontrib><creatorcontrib>Wang, Qian</creatorcontrib><creatorcontrib>Liu, Guibo</creatorcontrib><creatorcontrib>Zhao, Guiqiu</creatorcontrib><creatorcontrib>Cui Li</creatorcontrib><title>Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis</title><title>Experimental eye research</title><addtitle>Exp Eye Res</addtitle><description>Fungal keratitis (FK) is a refractory keratitis caused by excessive inflammation and fungal damage. Excessive inflammation can lead to tissue damage and corneal opacity, resulting in a poor prognosis for FK. Oxymatrine (OMT) is a natural alkaloid, which has rich pharmacological effects, such as antioxidant and anti-inflammation. However, its antifungal activity and the mechanism of action in FK have not been elucidated. This study confirmed that OMT suppressed Aspergillus fumigatus growth, biofilm formation, the integrity of fungal cell and conidial adherence. OMT not only effectively reduced corneal fungal load but also inflammation responses. OMT lessened the recruitment of neutrophils and macrophages in FK. In addition, OMT up-regulated the expression of Nrf2 and down-regulated the expression of IL-18, IL-1β, caspase-1, NLRP3 and GSDMD. Pre-treatment with Nrf2 inhibitor up-regulated the expression of IL-1β, IL-18, caspase-1, NLRP3 and GSDMD supressed by OMT. In conclusion, OMT has efficient anti-inflammatory and antifungal effects by suppressing fungal activity and restricting pyroptosis via Nrf2 pathway. OMT is considered as a potential option for the treatment of FK.
•Oxymatrine alleviated the severity of mouse fungal keratitis.•Oxymatrine exerted antifungal effects to suppress A. fumigatus growth.•Oxymatrine lessened infiltration of neutrophils and macrophages in mouse fungal keratitis.•Oxymatrine suppressed the excessive inflammatory response by inhibiting pyroptosis via Nrf2 pathway during fungal infections.</description><subject>Animals</subject><subject>Antifungal Agents - pharmacology</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Aspergillosis - drug therapy</subject><subject>Aspergillosis - metabolism</subject><subject>Aspergillus fumigatus - physiology</subject><subject>Aspergillus fumigatus keratitis</subject><subject>Caspase 1 - metabolism</subject><subject>Corneal Ulcer</subject><subject>Eye Infections, Fungal - drug therapy</subject><subject>Eye Infections, Fungal - metabolism</subject><subject>Inflammation</subject><subject>Interleukin-18</subject><subject>Keratitis - microbiology</subject><subject>Matrines</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>NF-E2-Related Factor 2</subject><subject>NLR Family, Pyrin Domain-Containing 3 Protein</subject><subject>NLRP3</subject><subject>Oxymatrine</subject><subject>Pyroptosis</subject><issn>0014-4835</issn><issn>1096-0007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9v1DAQxS1ERZfCF-CAcuSSZWJ7nUTiUlVtQarUC5wtx5msvOQfHqdqvn0n2sKRk0fvvXka_4T4VMC-gMJ8Pe3xGeNegtQs1JWCN2LHg8kBoHwrdgCFznWlDpfiPdGJVaVL_U5cqkoZXSu5E-Pj8zq4FMOI2RBSOLqElF3TjPEY-n6hrFuGTeXpN0aXOENZs2a0zHNEojAeOTIeXZ85n8JTSGvmxjZjj1tZYX9e4zSniQJ9EBed6wk_vr5X4tfd7c-b7_nD4_2Pm-uH3CsoU96VnUatD4XpmkYCGGOqRmvlD75rVVmqtpTgoWp1rRuD6FzXQFsylc2rvboSX869c5z-LHyKHQJ57Hs34rSQlbWspDZQAEflOerjRBSxs3MMg4urLcBunO3JbpztxtmeOfPS59f-pRmw_bfyFywHvp0DyL98CrxOPuDosQ0RfbLtFP7X_wKEapH4</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Liu, Weichen</creator><creator>Tian, Xue</creator><creator>Gu, Lingwen</creator><creator>Yu, Bing</creator><creator>Wang, Ziyi</creator><creator>Chi, Menghui</creator><creator>Lin, Jing</creator><creator>Wang, Qian</creator><creator>Liu, Guibo</creator><creator>Zhao, Guiqiu</creator><creator>Cui Li</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4643-072X</orcidid></search><sort><creationdate>202403</creationdate><title>Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis</title><author>Liu, Weichen ; Tian, Xue ; Gu, Lingwen ; Yu, Bing ; Wang, Ziyi ; Chi, Menghui ; Lin, Jing ; Wang, Qian ; Liu, Guibo ; Zhao, Guiqiu ; Cui Li</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-f7f4e44516fbb2006668b443c5cfd3773d720c08d494b6eeaafb0d7101773d9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Antifungal Agents - pharmacology</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Aspergillosis - drug therapy</topic><topic>Aspergillosis - metabolism</topic><topic>Aspergillus fumigatus - physiology</topic><topic>Aspergillus fumigatus keratitis</topic><topic>Caspase 1 - metabolism</topic><topic>Corneal Ulcer</topic><topic>Eye Infections, Fungal - drug therapy</topic><topic>Eye Infections, Fungal - metabolism</topic><topic>Inflammation</topic><topic>Interleukin-18</topic><topic>Keratitis - microbiology</topic><topic>Matrines</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>NF-E2-Related Factor 2</topic><topic>NLR Family, Pyrin Domain-Containing 3 Protein</topic><topic>NLRP3</topic><topic>Oxymatrine</topic><topic>Pyroptosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Weichen</creatorcontrib><creatorcontrib>Tian, Xue</creatorcontrib><creatorcontrib>Gu, Lingwen</creatorcontrib><creatorcontrib>Yu, Bing</creatorcontrib><creatorcontrib>Wang, Ziyi</creatorcontrib><creatorcontrib>Chi, Menghui</creatorcontrib><creatorcontrib>Lin, Jing</creatorcontrib><creatorcontrib>Wang, Qian</creatorcontrib><creatorcontrib>Liu, Guibo</creatorcontrib><creatorcontrib>Zhao, Guiqiu</creatorcontrib><creatorcontrib>Cui Li</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Weichen</au><au>Tian, Xue</au><au>Gu, Lingwen</au><au>Yu, Bing</au><au>Wang, Ziyi</au><au>Chi, Menghui</au><au>Lin, Jing</au><au>Wang, Qian</au><au>Liu, Guibo</au><au>Zhao, Guiqiu</au><au>Cui Li</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis</atitle><jtitle>Experimental eye research</jtitle><addtitle>Exp Eye Res</addtitle><date>2024-03</date><risdate>2024</risdate><volume>240</volume><spage>109830</spage><epage>109830</epage><pages>109830-109830</pages><artnum>109830</artnum><issn>0014-4835</issn><eissn>1096-0007</eissn><abstract>Fungal keratitis (FK) is a refractory keratitis caused by excessive inflammation and fungal damage. Excessive inflammation can lead to tissue damage and corneal opacity, resulting in a poor prognosis for FK. Oxymatrine (OMT) is a natural alkaloid, which has rich pharmacological effects, such as antioxidant and anti-inflammation. However, its antifungal activity and the mechanism of action in FK have not been elucidated. This study confirmed that OMT suppressed Aspergillus fumigatus growth, biofilm formation, the integrity of fungal cell and conidial adherence. OMT not only effectively reduced corneal fungal load but also inflammation responses. OMT lessened the recruitment of neutrophils and macrophages in FK. In addition, OMT up-regulated the expression of Nrf2 and down-regulated the expression of IL-18, IL-1β, caspase-1, NLRP3 and GSDMD. Pre-treatment with Nrf2 inhibitor up-regulated the expression of IL-1β, IL-18, caspase-1, NLRP3 and GSDMD supressed by OMT. In conclusion, OMT has efficient anti-inflammatory and antifungal effects by suppressing fungal activity and restricting pyroptosis via Nrf2 pathway. OMT is considered as a potential option for the treatment of FK.
•Oxymatrine alleviated the severity of mouse fungal keratitis.•Oxymatrine exerted antifungal effects to suppress A. fumigatus growth.•Oxymatrine lessened infiltration of neutrophils and macrophages in mouse fungal keratitis.•Oxymatrine suppressed the excessive inflammatory response by inhibiting pyroptosis via Nrf2 pathway during fungal infections.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>38364932</pmid><doi>10.1016/j.exer.2024.109830</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-4643-072X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-4835 |
ispartof | Experimental eye research, 2024-03, Vol.240, p.109830-109830, Article 109830 |
issn | 0014-4835 1096-0007 |
language | eng |
recordid | cdi_proquest_miscellaneous_2928246010 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Antifungal Agents - pharmacology Antifungal Agents - therapeutic use Aspergillosis - drug therapy Aspergillosis - metabolism Aspergillus fumigatus - physiology Aspergillus fumigatus keratitis Caspase 1 - metabolism Corneal Ulcer Eye Infections, Fungal - drug therapy Eye Infections, Fungal - metabolism Inflammation Interleukin-18 Keratitis - microbiology Matrines Mice Mice, Inbred C57BL NF-E2-Related Factor 2 NLR Family, Pyrin Domain-Containing 3 Protein NLRP3 Oxymatrine Pyroptosis |
title | Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T08%3A26%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxymatrine%20mitigates%20Aspergillus%20fumigatus%20keratitis%20by%20suppressing%20fungal%20activity%20and%20restricting%20pyroptosis&rft.jtitle=Experimental%20eye%20research&rft.au=Liu,%20Weichen&rft.date=2024-03&rft.volume=240&rft.spage=109830&rft.epage=109830&rft.pages=109830-109830&rft.artnum=109830&rft.issn=0014-4835&rft.eissn=1096-0007&rft_id=info:doi/10.1016/j.exer.2024.109830&rft_dat=%3Cproquest_cross%3E2928246010%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2928246010&rft_id=info:pmid/38364932&rft_els_id=S0014483524000514&rfr_iscdi=true |